Browse

Poster Abstracts

C001

OVEREXPRESSION OF HOMOLOGOUS REPAIR PROTEINS IN HUMAN PAPILLOMAVIRUS POSITIVE HEAD AND NECK SQUAMOUS CELL CARCINOMA BY IMMUNOHISTOCHEMISTRY ANALYSIS. A POTENTIAL TARGET FOR MOLECULAR THERAPIES.

Immunotherapy and Other Adjuvant Treatments

Andrew J Holcomb, MD1, Sufi Thomas, PhD1, Yelizaveta Shnayder, MD1, Rashna Madan, MD1, Ossama Tawfik, MD, PhD1, Nicholas Wallace, PhD2

1University of Kansas Medical Center, 2Kansas State University


C002

DEFINED GENETIC ALTERATIONS AS A BIOMARKER PREDICTING PROGNOSIS IN HPV-ASSOCIATED HEAD AND NECK CANCER.

Immunotherapy and Other Adjuvant Treatments

Andrew B Sewell, MD, Michael Hajek, MD, Cassie Pan, BS, Tejas Sather, BS, Wendell G Yarbrough, MD, MMHC, Natalia Issaeva, PhD

Yale University


C003

PLASMACYTOID DENDRITIC CELLS ARE DISTINCTLY IMMUNOSTIMULATORY IN HPV-POSITIVE HNSCC

Immunotherapy and Other Adjuvant Treatments

Kate Poropatich, Sandeep Samant, Bin Zhang

Northwestern University


C004

HIGH THROUGHPUT DRUG TESTING IDENTIFIES AGENTS WITH SELECTIVE ACTIVITY IN HPV-POSITIVE AND HPV-NEGATIVE CELL LINES

Immunotherapy and Other Adjuvant Treatments

Farhad Ghasemi, BSc1, Morgan D Black, BSc, MSc1, Alessandro Datti, PhD2, John W Barrett, PhD1, John Yoo, MD1, Kevin Fung, MD1, S D MacNeil, MD, MSc1, Anthony C Nichols, MD1

1Western University, 2Lunenfeld Tanenbaum Research Institute


C005

LEVEL OF LYMPH NODE METASTASIS ADDS PROGNOSTIC VALUE TO AMERICAN JOINT COMMITTEE ON CANCER NODAL STAGING FOR SQUAMOUS CELL CARCINOMA OF THE FLOOR OF MOUTH

Oral Cancer

Alexander N Goel, BA, Suraj A Dhanjani, Albert Y Han, MD, Karam W Badran, MD, Maie A St. John, MD, PhD

Department of Head and Neck Surgery, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California, USA


C006

INHIBITION OF TRKB RECEPTOR ON THE MIGRATION OF HUMAN SCHWANN CELL AND ORAL TONGUE SQUAMOUS CELL CARCINOMA IN VITRO

Oral Cancer

Liliana Ein, MD1, Olena Bracho, BS1, Paula Monje, PhD1, Cristina Fernandez, PhD2, Giovana Thomas, MD1, Donald Weed, MD1, Zoukaa Sargi, MD, MPH1, Christine Dinh, MD1

1University of Miami Miller School of Medicine, 2University of Central Florida Burnett School of Biomedical Sciences


C007

NODAL YIELD AND LOG ODDS RATIO ARE ASSOCIATED WITH SURVIVAL OUTCOMES IN EARLY STAGE CLINICALLY NODE-NEGATIVE ORAL CAVITY SQUAMOUS CELL CARCINOMA

Oral Cancer

Anuraag S Parikh, MD, Ayaz Khawaja, MD, Besher Assi, Joseph Zenga, MD, Mark A Varvares, MD

Massachusetts Eye and Ear Infirmary


C008

FACTORS PREDICTIVE OF ELECTIVE NECK DISSECTION (END) IN PATIENTS WITH CN0 HARD PALATE AND UPPER GINGIVAL SCC AND THE IMPACT OF END ON SURVIVAL

Oral Cancer

A Obayemi, MD1, M Cohen, MD1, R Rahmati, MD2, J Migliacci1, J C Cracchiolo1, B Roman1

1Memorial Sloan Kettering Cancer Center, 2Columbia University Medical Center


C009

VALIDATION OF AN UPDATED GRAPHIC EDUCATION TOOL IN AN ORAL RINSE POINT-OF-CARE ASSAY TO AID IN THE DIAGNOSIS OF HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC)

Oral Cancer

Michael J Donovan, Dr1, Greg Ginn2, Elizabeth Franzmann, MD3

1Icahn School of Medicine at Mt. Sinai, 2Vigilant Biosciences, 3University of Miami


C010

A POPULATION-BASED ANALYSIS OF A RARE NASOPHARYNGEAL MALIGNANCY: 1677 CASES OF LYMPHOEPITHELIAL CARCINOMA

Oral Cancer

Neel R Sangal, BA, Sarangdev Vaidya, BA, Monica C Azmy, BS, Jean Anderson Eloy, MD, FACS, Soly Baredes, MD, FACS, Richard C Park, MD, FACS

New Jersey Medical School